IL160531A0 - Compositions and methods for aa4rp assay - Google Patents

Compositions and methods for aa4rp assay

Info

Publication number
IL160531A0
IL160531A0 IL16053102A IL16053102A IL160531A0 IL 160531 A0 IL160531 A0 IL 160531A0 IL 16053102 A IL16053102 A IL 16053102A IL 16053102 A IL16053102 A IL 16053102A IL 160531 A0 IL160531 A0 IL 160531A0
Authority
IL
Israel
Prior art keywords
aa4rp
compositions
methods
assay
relates
Prior art date
Application number
IL16053102A
Other languages
English (en)
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0111598A external-priority patent/FR2829581A1/fr
Priority claimed from FR0210205A external-priority patent/FR2843395A1/fr
Application filed by Genfit filed Critical Genfit
Publication of IL160531A0 publication Critical patent/IL160531A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL16053102A 2001-09-07 2002-09-06 Compositions and methods for aa4rp assay IL160531A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0111598A FR2829581A1 (fr) 2001-09-07 2001-09-07 Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose
FR0210205A FR2843395A1 (fr) 2002-08-12 2002-08-12 Composition et methodes pour le dosage de l'aa4rp
PCT/FR2002/003041 WO2003023408A1 (fr) 2001-09-07 2002-09-06 Compositions et methodes pour le dosage de l'aa4rp

Publications (1)

Publication Number Publication Date
IL160531A0 true IL160531A0 (en) 2004-07-25

Family

ID=26213176

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16053102A IL160531A0 (en) 2001-09-07 2002-09-06 Compositions and methods for aa4rp assay

Country Status (10)

Country Link
US (1) US20040197823A1 (xx)
EP (1) EP1423708B1 (xx)
JP (1) JP2005502711A (xx)
AT (1) ATE347108T1 (xx)
CA (1) CA2459947A1 (xx)
DE (1) DE60216482T2 (xx)
DK (1) DK1423708T3 (xx)
ES (1) ES2275924T3 (xx)
IL (1) IL160531A0 (xx)
WO (1) WO2003023408A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972802B2 (en) * 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0976824A1 (en) * 1998-07-10 2000-02-02 Amsterdam Molecular Therapeutics Gene and protein involved in liver regeneration
US6455280B1 (en) * 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
EP1144444A3 (en) * 1998-12-22 2002-01-02 Genset Dnas encoding proteins with signal sequences
ATE348108T1 (de) * 1999-03-08 2007-01-15 Genentech Inc Methode zum nachweis von tumoren
CA2368098A1 (en) * 1999-06-25 2001-01-04 Genset S.A. Complementary dna's encoding proteins with signal peptides
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
AU2001253620A1 (en) * 2000-04-14 2001-10-30 Nuvelo, Inc. Materials and methods relating to lipid metabolism

Also Published As

Publication number Publication date
DE60216482T2 (de) 2007-08-23
DK1423708T3 (da) 2007-04-02
WO2003023408A1 (fr) 2003-03-20
EP1423708A1 (fr) 2004-06-02
CA2459947A1 (fr) 2003-03-20
EP1423708B1 (fr) 2006-11-29
ATE347108T1 (de) 2006-12-15
DE60216482D1 (de) 2007-01-11
US20040197823A1 (en) 2004-10-07
JP2005502711A (ja) 2005-01-27
ES2275924T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
EP1379693A4 (en) BIO STICK CODES BASED ON OLIGONUCLEOTIDE-MODIFIED PARTICLES
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
WO2003064993A3 (en) Methods and materials for detecting genetic material
CA2285918A1 (en) Methods for concentrating ligands using magnetic particles
WO2002055985A3 (en) Methods and reagents for identifying rare fetal cells in the material circulation
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
AU3538195A (en) Assays and devices for the detection of extrahepatic biliary atresia
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
WO2004019000A3 (en) Chemical reagents and methods for detection and quantification of proteins in complex mixtures
WO2003106964A3 (en) HIGH EFFICIENCY METHODS AND DEVICES FOR ASSAYING ANALYTES IN A FLUID SAMPLE
WO2005003394A3 (en) Bio-barcode based detection of target analytes
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
EP0873998A3 (en) Receptor protein and its use
EP0753743A3 (en) Vitamin D assay
EP1424558A4 (en) REAGENT FOR TESTING LAMININE-5-ANTIGENS IN A BIOLOGICAL SAMPLE AND TEST PROCEDURE
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
CA2341263A1 (en) Enzyme inhibition immunoassay
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
IL160531A0 (en) Compositions and methods for aa4rp assay
WO2002059600A3 (en) Analyte detection
EP1441224A3 (en) Enzyme inhibition immunoassay